gastric-cancer

Documents about gastric-cancer

• Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer#832900ClinicalTrials.gov
• A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients#982397ClinicalTrials.gov
• A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer#851882ClinicalTrials.gov
• A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)#867064ClinicalTrials.gov
• A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors#858509ClinicalTrials.gov
• Gastric Cancer Liver Metastasis Cohort of China#208437ClinicalTrials.gov
• Stage analysis of gastric cancer: a bioinformatic approach.#418296NCBI PubMed Central
• Exploratory Study of Single-port Robot-assisted Gastrectomy#867527ClinicalTrials.gov
• The Efficacy and Safety of Benmelstobart for GC/EGC#982758ClinicalTrials.gov
• A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer#967481ClinicalTrials.gov
• Additional file 1 of Computationally guided multi-epitope vaccine design targeting oncoprotein BZLF1, EBNA1, LMP1, and LMP2 for of EBV associated gastric cancer#652507Figshare
• Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients#804240ClinicalTrials.gov
• Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma#915950ClinicalTrials.gov
• Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma#250573IRIS
• Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection#873762ClinicalTrials.gov
• FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer#968955ClinicalTrials.gov
• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma#828932ClinicalTrials.gov
• Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)#835744ClinicalTrials.gov
• HER-2 B Cell Peptide Vaccine#454018ClinicalTrials.gov
• AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract#968302ClinicalTrials.gov
• Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.#253008ClinicalTrials.gov
• A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors#877594ClinicalTrials.gov
• Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.#405169ClinicalTrials.gov
• Gastric cancer secondary prevention in dyspeptic patients#142755Springer Nature OA
• Anxiety Before Non-cardiac Surgery in Adults#848188ClinicalTrials.gov
• Early Oral Feeding After Total Gastrectomy for Cancer#882543ClinicalTrials.gov
• Combination of TATE and PD-1 Inhibitor in Liver Cancer#912261ClinicalTrials.gov
• Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer#185551IRIS
• A germline variant of ring finger protein 43 in an early onset, treatment-resistant metastatic gastric cancer: a case report#428461Repositorio Universidad del Desarrollo
• Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer#481757ClinicalTrials.gov
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction#810374ClinicalTrials.gov
• KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer#853890ClinicalTrials.gov
• Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study#217073ClinicalTrials.gov
• Validation of Textbook Outcome in Gastric Surgery (TOGS) for Primary Gastric Cancer in an Eastern High-Volume Center#345892Springer Nature OA
• Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)#834679ClinicalTrials.gov
• A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer#969307ClinicalTrials.gov
• DNX-2440 for Resectable Colorectal Liver Metastasis#830024ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)#829371ClinicalTrials.gov
• Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients#879625ClinicalTrials.gov
• Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors#889170ClinicalTrials.gov
• PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis#842522ClinicalTrials.gov
• Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ#346931ClinicalTrials.gov
• GutCore: An Endoscopy Foundation Model for Whole-Case Gastric Cancer Analysis#459880bioRxiv / medRxiv
• Circulating Levels of Sex Steroid Hormones and Gastric Cancer.#610573NCBI PubMed Central
• Lipid metabolism and the immune microenvironment in gastric cancer.#653441NCBI PubMed Central
• A Real World Study of Laparoscopic Preservation of the Pylorus Gastrectomy#836553ClinicalTrials.gov
• Prospective Observational Cohort Study#858514ClinicalTrials.gov
• ICG-NIR Guided Lymph Node Dissection in Gastric Cancer#858969ClinicalTrials.gov
• Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery#970017ClinicalTrials.gov
• Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients#810128ClinicalTrials.gov